购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

NVP-AEW541

Rating icon 很棒
产品编号 T6080Cas号 475489-16-8
别名 AEW541

NVP-AEW541 (AEW541) 是一种IGF-1R 抑制剂,IC50为 0.15 μM。它也抑制InsR,IC50为 0.14 μM。

NVP-AEW541

NVP-AEW541

Rating icon 很棒
纯度: 99.55%
产品编号 T6080 别名 AEW541Cas号 475489-16-8

NVP-AEW541 (AEW541) 是一种IGF-1R 抑制剂,IC50为 0.15 μM。它也抑制InsR,IC50为 0.14 μM。

规格价格库存数量
1 mg
¥ 495
现货
2 mg
¥ 725
现货
5 mg
¥ 1,230
现货
10 mg
¥ 1,970
现货
25 mg
¥ 3,160
现货
50 mg
¥ 4,750
现货
1 mL x 10 mM (in DMSO)
¥ 1,360
现货
大包装 & 定制
加入购物车
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
实验操作小课堂
常见问题解答
查看更多

"NVP-AEW541"的相关化合物库

选择批次:
纯度:99.55%
联系我们获取更多批次信息

产品介绍

生物活性
产品描述
NVP-AEW541 (AEW541), a potent inhibitor of IGF-1R(IC50=150 nM) and InsR(IC50=140 nM), exhibits excellent efficiency and specificity for IGF-1R in a cell-based assay.
靶点活性
IGF-1R:0.15 μM, Insulin receptor:0.14 μM
体外活性
NVP-AEW541可抑制InsR、Tek、Flt1和Flt3的活性,其IC50分别为140 nM、530 nM、600 nM和420 nM,表现在纯化激酶/重组激酶域测定中。其对细胞水平上InsR的选择性更高,效力提高了27倍。NVP-AEW541能够抑制IGF-I介导的MCF-7细胞存活、软琼脂生长及增殖,相应IC50为0.162 μM、0.105 μM和1.64 μM。同时,NVP-AEW541还能降低NWT-21细胞中的磷酸化IGF-1R和磷酸化PKB水平。[1] NVP-AEW541显示出在低血清培养基及含10% FBS培养基中对TC-71肌肉骨骼肉瘤细胞的生长抑制效果,并在肉瘤细胞系(TC-71, SK-N-MC, SaoS-2, RD/18和RH4)中抑制细胞周期进程,诱导特异性G1阶段阻滞。[2] NVP-AEW541能抑制人类神经母细胞瘤细胞的生长,IC50范围为0.4-6.8 μM。这些细胞系可检测到次二倍体分数增加以及S和G2-M部分的耗尽。NVP-AEW541驱动的IGF-1R抑制导致Akt磷酸化减少,但不影响Erk1和Erk2。[3] NVP-AEW541抑制胶质瘤细胞生长并破坏由HIF1α稳定化引起的自分泌回路。[4] 最近的研究显示,NVP-AEW541抑制PC3、DU145和22Rv1前列腺癌细胞的增殖和活力,而不必然导致相关细胞死亡。NVP-AEW541在22Rv1和DU415细胞中降低磷酸化Akt水平,但PC3细胞除外,不影响总Akt水平,表明PTEN状态可能决定了含必需Akt的NVP-AEW541的有效性。NVP-AEW541诱导的增敏作用依赖于Akt激活状态。NVP-AEW541能增加PC3、DU145和22Rv1细胞中H2AX磷酸化(DSB的一个衡量指标)。[5]
体内活性
NVP-AEW541(50 mg/kg,口服)能够抑制基础及IGF-I诱导的受体以及PKB和MAPK的磷酸化,NWT-21肿瘤移植物中的T/C值为14%。[1] NVP-AEW541(50 mg/kg)在HTLA-230和SK-N-BE2c肿瘤移植物中均能引起肿瘤缩小,且未见全身毒性迹象。NVP-AEW541能够在Matrigel-coated室和HTLA-230肿瘤移植物中抑制肿瘤侵袭。[3]
激酶实验
In vitro kinase assays: NVP-AEW541 is dissolved in DMSO (10 mM) and stored at -20 °C. Dilutions are freshly made in DMSO/water 1:1. The final concentration of DMSO in the enzyme assays is <0.5 %. The protein kinase assays are carried out in 96-well plates at RT and terminated by the addition of 20 μL of 125 mM EDTA. Subsequently, 30 μL (c-Abl, c-Src, IGF-1R) of the reaction mixture are transferred onto Immobilon-PVDF presoaked for 5 min with methanol, rinsed with water, then soaked for 5 min with 0.5 % H3PO4 and mounted on vacuum manifold. After spotting all samples, vacuum is connected and each well rinsed with 200 μL 0.5 % H3PO4. Membranes are removed and washed 4× on a shaker with 1.0 % H3PO4, once with ethanol. After drying, mounting in Packard TopCount 96-well frame, and adding of 10 μL/well of Microscint, membranes are counted. IC50 values are calculated by linear regression analysis of the percentage inhibition of NVP-AEW541 in duplicate, at four concentrations (usually 0.01, 0.1, 1, and 10 μM). One unit of protein kinase activity is defined as 1 nmol of 33P transferred from [γ33P]ATP to the substrate protein per minute per mg of protein at 37 °C.
细胞实验
Between 3 × 103 and 6 × 103 cells/well are seeded in 96-well plates with a total media volume of 100 μL/well. Increasing concentrations of NVP-AEW541 is added 24 hours thereafter in quadruplicate. 72 hours later, cells are fixed by addition of 25 μL/well Glutaraldehyde (20%) and incubation for 10 min at RT. Cells are then washed 2× with 200 μL/well Water and 100 μL Methylene Blue (0.05%) is added. After incubation for 10 min at RT, cells are washed 3× with 200 μL/well Water. 200 μL/well HCl (3%) is added, and following incubation for 30 min at RT on a plate shaker, absorbance is measured at 650 nm.(Only for Reference)
别名AEW541
化学信息
分子量439.55
分子式C27H29N5O
CAS No.475489-16-8
SmilesNc1ncnc2n(cc(-c3cccc(OCc4ccccc4)c3)c12)C1CC(CN2CCC2)C1
密度1.33 g/cm3
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
DMSO: 51 mg/mL (116.03 mM), Sonication is recommended.
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
溶液配制表
DMSO
1mg5mg10mg50mg
1 mM2.2751 mL11.3753 mL22.7505 mL113.7527 mL
5 mM0.4550 mL2.2751 mL4.5501 mL22.7505 mL
10 mM0.2275 mL1.1375 mL2.2751 mL11.3753 mL
20 mM0.1138 mL0.5688 mL1.1375 mL5.6876 mL
50 mM0.0455 mL0.2275 mL0.4550 mL2.2751 mL
100 mM0.0228 mL0.1138 mL0.2275 mL1.1375 mL

SCI 文献

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy NVP-AEW541 | purchase NVP-AEW541 | NVP-AEW541 cost | order NVP-AEW541 | NVP-AEW541 chemical structure | NVP-AEW541 in vivo | NVP-AEW541 in vitro | NVP-AEW541 formula | NVP-AEW541 molecular weight